Ionis Pharmaceuticals Inc
IONS· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Revenue | $120.43M | $57.08M | $38.09M | $47.34M |
| Net Income | $35.65M | -$12.08M | -$10.13M | — |
| EPS Diluted | $0.29 |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
| -$0.10 |
| -$0.09 |
| -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.